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Manganese is ubiquitous in the environment.
It is essential for physiologic functioning in
trace quantities, usually supplied by dietary
intake. Adverse health effects are typically
associated with inhalation exposures within
occupational settings, such as the steel or min-
ing industry, and are characterized by neuro-
logic effects [Agency for Toxic Substances and
Disease Registry (ATSDR) 2000]. Classical
manganism presents with generally irreversible
Parkinson-like symptoms (Jiang et al. 2006),
which often progress even after exposure ends
(Huang et al. 1993). Little is known about the
potential health effects resulting from exces-
sive ingestion exposures.
In this report we describe the investiga-
tion of a case of pediatric manganism with
ingestion exposures. The objectives of this
investigation were to confirm the diagnosis,
identify the underlying etiology, recommend
control measures, and assess whether other
persons were at risk.
Case Presentation
In August 2004, a previously healthy 6-year-
old female presented with pica and emotional
lability. Over the following months she devel-
oped progressive behavioral and neurologic
symptoms: She became withdrawn and less
verbal with repetitive stuttered speech, and
her balance, co-ordination, and fine motor
skills declined. By November, she could no
longer stand independently, tended to fall
backward, and developed a high steppage
“cock-like” gait.
Magnetic resonance imaging (MRI) indi-
cated hyperintensity in the basal ganglia, sug-
gesting Mn accumulation. Blood samples
analyzed with high-resolution inductively cou-
pled plasma mass spectrometry conﬁrmed ele-
vated levels of Mn in whole blood (39.7 µg/L;
normal, 4.3–15.9 µg/L) and serum specimens
(3.2 µg/L; normal, 0.3–1.0 µg/L). Severe
Fe deficiency [ferritin, 5 µg/L (normal,
12–140 µg/L); serum Fe, 5 µmol/L (normal
5–28 µmol/L)] and polycythemia [red blood
cells (RBCs), 7.6 × 1012/L; normal, 3.9–5.3 ×
1012/L) were identified; polycythemia was
attributed to elevated Co (3.9 µg/L; normal:
0.7–0.8 µg/L). Blood lead was normal
(2.9 µg/dL; normal, 0–4.6 µg/dL) in October
2004 but elevated (17.6 µg/dL) in early August
2005. Investigations failed to determine a cause
for the manganism. The patient’s karyotype
was normal. A liver biopsy ruled out hepatic
dysfunction; however, liver Mn was elevated
(34 µg/g; normal, 0.22–4.6 µg/g). Normal
blood copper levels ruled out Wilson’s disease.
Treatment included phlebotomies for the
polycythemia (November 2004–February
2005, October–November 2005), ethylene-
diamine tetraacetic acid chelation for the Mn
overload (March–December 2005), and Fe
therapy (November 2004–July 2005,
October–November 2005). Significant
improvements in gait, retropulsion, and motor
skills that were observed after the initiation of
the phlebotomies and chelation plateaued after
a few treatments.
In July 2005, Fe supplementation was
stopped; a precipitous drop in the patient’s Fe
levels immediately followed. Her plasma and
RBC Mn levels began rising again (Figures 1
and 2). By August her condition had deterio-
rated: Her pica returned, she fell frequently,
and she needed assistance where she was previ-
ously independent. Neurologists estimated
that one-fourth of her improvements were
lost. Phlebotomies and oral Fe therapy were
re-initiated in October.
Exposure assessment. The patient resided
with her mother, father, and 7-year-old sister
in an urban center in New Brunswick (NB),
Canada. Since 2000, they have spent sum-
mers at their nearby cottage—weekend visits
in June, followed by full time residence in
July and August.
Water testing was conducted; municipal
water consumed at the primary residence had
nondetectable Mn. At the cottage, a sandpoint
well used between 2000 and 2003 had Mn
concentrations of 1.7–2.4 mg/L (the health
guideline is 0.5 mg/L) (World Health
Organization 2006). Spring water and a neigh-
boring cottage well used in 2004 had non-
detectable concentrations and 1.7–2.2 mg/L
Mn, respectively. In 2005 municipal water was
brought to the cottage for drinking, but use of
well water for washing and cooking continued.
A food history revealed that the patient
and her family consumed more vegetables than
a typical Canadian family, particularly Mn-
rich leafy green vegetables and pineapples, but
they were not vegetarian. Foods consumed by
the patient and her sibling were very similar
with one exception: The sibling consumed soy
milk due to lactose intolerance, whereas the
patient consumed dairy. Both took half of a
children’s vitamin supplement daily.
No inhalation exposures were identified.
No industrial Mn releases were reported in
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article we describe the investigation of a pediatric case of manganism using both clinical and envi-
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[Online 23 August 2007]the vicinity of either the primary residence or
the cottage (Environment Canada 2003).
Neither residence was located in high traffic
environments; excessive exposure to methyl-
cyclopentadienyl manganese tricarbonyl was
therefore unlikely. Parental occupations did
not involve exposure to Mn.
Site visits to the primary residence and
cottage did not identify excessive exposure
sources unique to the patient. No recent reno-
vations, painting, or household products con-
taining Mn were identified. Household
members did not participate in hobbies associ-
ated with Mn exposure such as glasswork or
ceramics. The father infrequently used a weld-
ing torch in the detached garage of the pri-
mary residence; the children were restricted
from the garage during welding but otherwise
had free access. During the summer months,
vegetables consumed by the patient and her
family came predominantly from their cottage
garden. Agricultural products containing Mn
(e.g., fungicides) were not used. Satellite
imagery and site visits did not identify other
Mn sources in the vicinity of either residence.
Exposures were very similar for the whole
family and virtually identical for the patient
and her sister, as they spent the majority of
their time together. Only pica was unique to
the patient.
Assessment of other persons at risk. The
patient’s parents and sibling were asympto-
matic. Between March and June 2005, the
immediate family and five extended family
members (maternal grandparents, paternal
grandfather, and the father’s two siblings in
lieu of the deceased paternal grandmother),
were tested for Mn. Results indicated elevated
plasma Mn ranging from 1.9 to 2.8 µg/L
(normal, 0.3–1.0 µg/L) for everyone except
the patient’s sister; her plasma Mn was normal
(0.6 µg/L) in March but elevated (2.3 µg/L)
when retested in May. All those tested had
RBC Mn within the normal range (Figures 1
and 2).
Genetic counseling did not identify a
familial cause. Both maternal and paternal
families are NB Acadian for at least three gen-
erations, with no identified consanguinity.
No history of Fe deﬁciency, neurologic disor-
ders (e.g., Parkinson disease), or metabolic
disorders were identiﬁed.
Early stages of Mn toxicity include muscle
tremors and can sometimes resemble
Parkinson disease, which has been proposed as
a sentinel among selected occupational groups
(Harvard Medical School 2000). We exam-
ined hospital separation data for Parkinsonism
between 1991 and 1995 in which NB rates
were similar to other Canadian provinces
(Kontakos and Stokes 2000).
Specialists considered this case unique.
They queried an international metabolic list-
serv to identify other clinically similar cases,
and identiﬁed a girl with hypermanganesemia
of unknown origin in a consanguineous family
in the United Kingdom. Her MRI indicated
increased intensity in the basal ganglia, and she
had a “cock-like” gait. She was polycythemic
with elevated iron-binding capacity but had
normal serum Fe. We also identiﬁed a single
case from the literature—a boy from California
with polycythemia and manganism explained
by liver dysfunction (Gospe et al. 2000).
Discussion
The patient’s symptoms, biomonitoring results,
and environmental assessment were consistent
with a chronic, seasonal exposure pattern.
Symptom onset occurred in August 2004 with
a relapse 1 year later, which was preceded by an
increase in blood plasma Mn in early June
2005. The timing of the increase was consistent
with ﬁndings of increased ingestion exposures
at the cottage during the summer months.
Unfortunately, continuous biomonitoring of
the immediate family’s blood Mn concentra-
tions during the summer was not conducted. A
synchronous increase in the family’s Mn levels
would have supported the hypothesis that the
seasonal cottage exposure was responsible for
the patient’s increase in Mn.
The clinical, laboratory, and imaging
results support a diagnosis of manganism;
however, the patient’s increased Co levels have
yet to be explained. Her severe Fe deﬁciency,
unusual for children of her age, is possibly
related to these two conditions.
Co can cause polycythemia through
increased erythropoiesis (ATSDR 2004).
Phlebotomies used to treat the polycythemia
may have exacerbated the Fe deﬁciency. Low
Fe can enhance Mn absorption (Finley 1999;
Roth and Garrick 2003); the cessation of Fe
Metabolic disorder presenting as manganism
Environmental Health Perspectives • VOLUME 115 | NUMBER 12 | December 2007 1777
Figure 1. Timeline of Mn levels in plasma for the patient and her family (immediate and extended),
March–October 2005. Abbreviations: Max, maximum; Min, minimum. 
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Figure 2. Timeline of Mn levels in RBCs for the patient and her family (immediate and extended),
March–October 2005. Abbreviations: Max, maximum; Min, minimum. supplementation and concurrent depletion of
ferritin stores in 2005 possibly contributed to
an increased absorption of the Mn at the
cottage. However, this does not fully explain
the increased blood Mn, as laboratory data
clearly indicates that the rise in plasma Mn
occurred before the decline in ferritin levels
(Figure 3). Ongoing chelation therapy may
have also precipitated a release of Mn body
stores, contributing to increased blood Mn in
the summer and fall of 2005; it remains
unclear if this alone could explain the magni-
tude of the increase.
Females absorb Co and Mn more effec-
tively, and animal studies indicate that the
young may absorb more than adults (ATSDR
2000, 2004; Nieboer 2001). Mn, Fe, and Co
are divalent cations; all three metals are
thought to utilize the same intestinal trans-
porters, and all are essential for proper bodily
functioning (ATSDR 2004; Nieboer 2001).
An up-regulation of this intestinal transporter
is a possible underlying cause of this disorder.
We propose that the presence of a meta-
bolic disorder involving Fe, Mn, and Co, inter-
acting with the cottage environment, may
explain the patient’s condition. This may be
caused by an underlying genetic or epigenetic
defect. Precedents for genetic disorders that are
diagnosed after an apparently healthy child-
hood are numerous (e.g., Tay-Sachs disease,
muscular dystrophy). An inherited genetic dis-
order with variable penetrance or copy-number
variations might explain the elevated blood Mn
in the asymptomatic extended family members.
Acadian backgrounds have been associated with
a high incidence of genetic disorders (Lacassie
and Flórez 2007); although no parental consan-
guinity was identiﬁed within three generations,
more distant family ties cannot be ruled out.
Other persons at risk. The patient and her
immediate family shared very similar high
Mn ingestion exposures except for pica; if
these exposures alone were responsible for the
patient’s adverse health outcome, then her
family members would also be expected to
exhibit symptoms of Mn toxicity.
Although the immediate and extended
family members were asymptomatic, all had
elevated plasma Mn (indicative of short-term
exposure), with RBC Mn within the normal
range (Figures 1 and 2). Elevated plasma Mn
may indicate chronic and/or excessive Mn
exposure because it is believed that an undeter-
mined exposure threshold must be reached
before Mn accumulation occurs in RBC
(F. Leung, personal communication). It is
unknown whether these markers would consis-
tently precede clinical symptoms and therefore
could be used to monitor the patient’s sibling
for similar metabolic deterioration. 
Well water in NB and other Maritime
provinces commonly exceeds the health-based
drinking water guidelines for Mn due to
the underlying geology (New Brunswick
Department of Environment and Local
Government 2004). Because generations of
rural residents have relied on groundwater
containing high Mn concentrations, it seems
that selective pressures would have previously
highlighted any genetic disorders that disrupt
normal Mn homeostasis. Yet pediatric special-
ists considered this case presentation unique.
Also, provincial Parkinsonism rates were com-
parable to the rest of Canada (Kontakos and
Stokes 2000); this crude indicator suggests early
manganism symptoms were not artificially
inﬂating the Parkinson disease rates in NB.
The literature suggests a spectrum of dis-
ease, from the more severe forms of mangan-
ism to more subtle neurologic health effects.
Some studies have reported associations
between Mn exposure in drinking water and
reported cognitive/behavioral problems in
children in Quebec (Bouchard et al. 2007),
Bangladesh (Wasserman et al. 2006), and
Tawain (He et al. 1994). Similar long-term
Mn exposure studies in adults have been
mixed, with some researchers describing neu-
rologic dysfunction with increasing levels of
Mn in drinking water (Kondakis et al. 1989)
while others found no neurologic differences
(Vieregge et al. 1995). The true health bur-
den of excessive Mn ingestion is currently
unknown.
Limitations. There currently is no “gold
standard” biomarker for Mn exposure. The
primary care team used plasma and RBC Mn
as indicators. These are effective tools in meas-
uring exposure differences between popu-
lations, but they are less reliable on an
individual level (Apostoli et al. 2000; Bader
et al. 1999; Institute for Environment and
Health 2004; Mergler 1999; Ostiguy et al.
2003). Whole blood may be the best indicator
for an individual (Takagi et al. 2002). It
remains unclear to what extent observed varia-
tions in a biomarker represent real variations
in exposure. For example, three consecutive
blood samples for plasma Mn taken from the
patient at the hospital on a single day showed
large variability: 0.6, 2.2, and 2.4 µg/L.
Comparing measurements between individu-
als may be subject to the same variability.
A lack of appropriate population reference
values further complicated the interpretation
of Mn blood tests. Reference ranges were
derived from population norms in southern
Ontario; the absence of available reference
levels for plasma and RBC Mn for popula-
tions exposed to higher natural background
levels (e.g., through drinking water) makes
the interpretation of such results difficult.
The seemingly elevated plasma Mn levels
among the patient’s family members may well
be within a “normal” range.
There is also no “gold standard” for
measuring health effects from excessive Mn.
Nonspecific neurobehavioral symptoms may
be overlooked or misdiagnosed. Members of
the patient’s immediate and extended family
had no overt symptoms attributable to man-
ganism, but they were not tested for opposi-
tional behavior and hyperactivity (Bouchard
et al. 2007), IQ (Wasserman et al. 2006),
short-term verbal and visual memory (Woolf
et al. 2002), or manual dexterity and visuo-
perceptive speed (He et al. 1994). Which
tests are best at detecting which health effects
in which populations is a nascent field of
investigation.
Conclusion and
Recommendations
The available evidence suggests that environ-
mental exposures alone are unlikely to be the
sole cause of this child’s illness; however, an
unidentified exposure as a result of her pica
Sahni et al.
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Figure 3. Timeline of ferritin and plasma Mn levels for the patient, October 2004–November 2005.
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cannot be excluded. A pervasive metabolic
disorder (Mn, Fe, Co) is a more plausible
explanation. This hypothesis could incorpo-
rate both the environmental exposures and
clinical/laboratory findings, but is limited
because the proposed underlying genetic
defect cannot be identiﬁed at this time.
Given the patient’s deteriorating clinical
status, we recommended that the family use
only municipal water because boiling foods in
the Mn-rich well water may concentrate this
cation (British Columbia Ministry of the
Environment 2007; Bouchard et al. 2007).
Also, the garage used for welding should
always be off-limits to the children. Finally,
controlling the pica and implementing a low-
Mn, Fe-rich diet in addition to ongoing Fe
supplementation would be helpful.
In addition to these patient-speciﬁc con-
trol measures, the broader issue of blood Mn
reference levels remains to be addressed. The
Canadian Health Measures Survey, which
will collect blood and urine samples from
5,000 randomly chosen adults from 15 cities
across Canada, begins its data collection in
the winter of 2007 (Statistics Canada 2006).
Mn is among the metals to be measured in
the survey participants.
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